Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds

被引:434
|
作者
Lin, CW [1 ]
Tsai, FJ
Tsai, CH
Lai, CC
Wan, L
Ho, TY
Hsieh, CC
Chao, PDL
机构
[1] China Med Univ Hosp, Dept Med Genet & Med Res, Taichung 404, Taiwan
[2] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung 404, Taiwan
[3] China Med Univ Hosp, Dept Lab Med, Clin Virol Lab, Taichung 404, Taiwan
[4] China Med Univ, Inst Chinese Med Sci, Taichung 404, Taiwan
[5] China Med Univ, Inst Integrat Chinese & Western Med, Taichung 404, Taiwan
[6] China Med Univ, Dept Pharm, Taichung 404, Taiwan
关键词
SARS-coronavirus; 3C-like protease; Isatis indigotica root; phenolic compounds;
D O I
10.1016/j.antiviral.2005.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The 3C-like protease (3CL(pro),) of SARS-coronavirus mediates the proteolytic processing of replicase polypeptides 1 a and 1 ab into functional proteins, becoming an important target for the drug development. In this study, Isatis indigotica root extract, five major compounds of I indigotica root, and seven plant-derived phenolic compounds were tested for anti-SARS-CoV 3CL(pro) effects using cell-free and cell-based cleavage assays. Cleavage assays with the 3CL(pro) demonstrated that IC50 values were in micromolar ranges for I indigotica root extract, indigo, sinigrin, aloe emodin and hesperetin. Sinigrin (IC50: 217 mu M) was more efficient in blocking the cleavage processing of the 3CL(pro), than indigo (IC50: 752 mu M) and beta-sitosterol (IC50: 1210 mu M) in the cell-based assay. Only two phenolic compounds aloe emodin and hesperetin dose-dependently inhibited cleavage activity of the 3CL(pro), in which the IC50 was 366 mu M for aloe emodin and 8.3 mu M for hesperetin in the cell-based assay. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 42
页数:7
相关论文
共 33 条
  • [21] Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties
    Chiou, Wei-Chung
    Lu, Hsu-Feng
    Hsu, Nung-Yu
    Chang, Tein-Yao
    Chin, Yuan-Fan
    Liu, Ping-Cheng
    Lo, Jir-Mehng
    Wu, Yeh B.
    Yang, Jinn-Moon
    Huang, Cheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [22] The newly emerged SARS-Like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease
    Ren, Zhilin
    Yan, Liming
    Zhang, Ning
    Guo, Yu
    Yang, Cheng
    Lou, Zhiyong
    Rao, Zihe
    [J]. PROTEIN & CELL, 2013, 4 (04) : 248 - 250
  • [23] In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV
    Chunduru, Kiran
    Sankhe, Runali
    Begum, Farmiza
    Sodum, Nalini
    Kumar, Nitesh
    Kishore, Anoop
    Shenoy, Rekha R.
    Rao, C. Mallikarjuna
    Saravu, Kavitha
    [J]. MEDICINAL CHEMISTRY, 2021, 17 (04) : 380 - 395
  • [24] In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations
    Ostertag, Luisa M.
    O'Kennedy, Niamh
    Horgan, Graham W.
    Kroon, Paul A.
    Duthie, Garry G.
    de Roos, Baukje
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2011, 55 (11) : 1624 - 1636
  • [25] New Potent SARS-CoV 3C-Like Protease Inhibitors Derived from Thieno[2,3-d]pyrimidine Derivatives
    Abd El-All, Amira S.
    Atta, Sanaa M. Sh.
    Roaiah, Hanaa M. F.
    Awad, Enas M.
    Abdalla, Mohamed M.
    [J]. ARCHIV DER PHARMAZIE, 2016, 349 (03) : 202 - 210
  • [26] A novel auto-cleavage assay for studying mutational effects on the active site of severe acute respiratory syndrome coronavirus 3C-like protease
    Shan, YF
    Li, SF
    Xu, GJ
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (02) : 579 - 583
  • [27] Computational investigation of drug bank compounds against 3C-like protease (3CLpro) of SARS-CoV-2 using deep learning and molecular dynamics simulation
    Tushar Joshi
    Priyanka Sharma
    Shalini Mathpal
    Tanuja Joshi
    Priyanka Maiti
    Mahesha Nand
    Veena Pande
    Subhash Chandra
    [J]. Molecular Diversity, 2022, 26 : 2243 - 2256
  • [28] Computational investigation of drug bank compounds against 3C-like protease (3CLpro) of SARS-CoV-2 using deep learning and molecular dynamics simulation
    Joshi, Tushar
    Sharma, Priyanka
    Mathpal, Shalini
    Joshi, Tanuja
    Maiti, Priyanka
    Nand, Mahesha
    Pande, Veena
    Chandra, Subhash
    [J]. MOLECULAR DIVERSITY, 2022, 26 (04) : 2243 - 2256
  • [29] Natural products repurposing of the H5N1-based lead compounds for the most fit inhibitors against 3C-like protease of SARS-CoV-2
    Parikesit, Arli Aditya
    Nurdiansyah, Rizky
    [J]. JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2021, 9 (05): : 730 - 745
  • [30] Synthesis of Isatin Derivatives Using Silver Nanoparticles as Green Catalyst: Study of Molecular Docking Interactions in SARS-CoV-2 3c-Like Protease and Determination of Cytotoxic Activities of the Compounds
    Packialakshmi P.
    Gobinath P.
    Vijayakumar K.
    Ali D.
    Alarifi S.
    Balasubramani R.
    Pitchaisangan
    Surendrakumar R.
    [J]. Journal of Nanomaterials, 2021, 2021